Details

Autor(en) / Beteiligte

• Schoser, Benedikt
• Montagnese, Federica
• Bassez, Guillaume
• Fossati, Barbara
• Gamez, Josep
• Heatwole, Chad
• Hilbert, James
• Kornblum, Cornelia
• Kostera-Pruszczyk, Anne
• Krahe, Ralf
• Lusakowska, Anna
• Meola, Giovanni
• Moxley, 3rd, Richard
• Thornton, Charles
• Udd, Bjarne
• Formaker, Paul

Titel

Consensus-based care recommendations for adults with myotonic dystrophy type 2

Ist Teil von

• Neurology. Clinical practice, 2019-08, Vol.9 (4), p.343-353

Ort / Verlag

United States: The American Academy of Neurology

Erscheinungsjahr

2019

Quelle

EZB Free E-Journals

Beschreibungen/Notizen

• Myotonic dystrophy type 2 (DM2) is a rare, progressive multisystem disease particularly affecting the skeletal muscle. A causal therapy is not yet available; however, prompt, appropriate symptomatic treatments are essential to limit disease-related complications. Evidence-based guidelines to assist medical practitioners in the care of DM2 patients do not exist. The Myotonic Dystrophy Foundation (MDF) previously worked with an international group of 66 clinicians to develop consensus-based care recommendations for myotonic dystrophy type 1. Following a similar approach, the MDF recruited 15 international clinicians with long-standing experience in the care of DM2 patients to develop consensus-based care recommendations. The single text procedure was adopted. This process generated a 4-page Quick Reference Guide and a comprehensive 55-page document that provides care recommendations for DM2 patients. The resulting recommendations will help standardize and improve care for DM2 patients and facilitate appropriate management in centers without neuromuscular specialists.